Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
530971000036116 | poractant alfa 120 mg / 1.5 mL intratracheal suspension, 1.5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
530981000036119 | poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | Is a | poractant alfa | true | Inferred relationship | Some | ||
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | has intended active ingredient | poractant alfa | true | Inferred relationship | Some | 555228060 | |
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | has Australian BoSS | poractant alfa | true | Inferred relationship | Some | 555228060 | |
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | has manufactured dose form | intratracheal suspension | true | Inferred relationship | Some | ||
poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | has unit of use | vial | true | Inferred relationship | Some | 555228061 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Curosurf 120 mg/1.5 mL intratracheal suspension, 1.5 mL vial | Is a | True | poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | Inferred relationship | Some | |
poractant alfa 120 mg/1.5 mL intratracheal suspension, 1.5 mL vial | has MPUU | True | poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set